Long-term use of certain contraception jabs linked to increased fracture risk
May 7th, 2010 - 12:08 pm ICT by ANIWashington, May 7 (ANI): DMPA, a commonly used injectible contraceptive, is associated with higher risk of bone fracture when used alone, and not in combination with estrogens, according to a new study.
The study was presented at the World Congress on Osteoporosis (IOF WCO-ECCEO10) in Florence, Italy.
Depot medroxyprogesterone acetate (DMPA) is a progestin-only long acting reversible hormonal contraceptive birth control drug which is injected every 3 months. It is used by more than 9 million women worldwide, with high usage among teenagers in Europe and the US.
Previous research has shown that use of DMPA is associated with impaired bone acquisition during adolescence and accelerated bone loss later in life, mainly in younger women with lower estrogen levels. However, few studies have looked into the impact of DMPA on fracture risk.
The study, conducted by researchers at the University Hospital Basel, Switzerland and the Boston University Medical Center, Lexington, USA, used a case-control analysis to evaluate the relationship between long-term use of DMPA, with or without estrogen, and the risk of fractures. The results show that in women below 50 years of age, longer-term use of DMPA of two and more years is associated with a 50 percent increased risk of fracture. For users of combined estrogen-containing oral contraceptives fracture risk was not increased. (ANI)
- Injectable, oral contraceptives 'don't affect glucose, insulin levels' - Dec 21, 2010
- Young women often fail to spot weight gain - Jan 11, 2012
- Postmenopausal hormone therapy 'ups breast cancer risk' - Oct 20, 2010
- Women on injectable birth control 'at higher bone loss risk' - Dec 22, 2009
- Breast cancer risk varies among different progestins used in hormone replacement therapy - Aug 11, 2010
- Vigorous exercise strengthens hip bones in kids - May 11, 2010
- Estrogen alone can cut risk of breast cancer - Dec 10, 2010
- Birth control jab doesn't make every woman prone to excessive weight gain - Jul 25, 2009
- Hormone therapy linked to increased breast cancer risk: Study - Aug 11, 2010
- Estrogen therapy 'ups kidney stones risk' in postmenopausal women - Oct 12, 2010
- Hormonal contraceptives change scent communication in primates - Jul 28, 2010
- Breast tenderness during hormone replacement therapy may indicate cancer risk - Oct 13, 2009
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
- Hormone therapies 'up breast cancer metastasis risk in post-menopausal women' - May 07, 2010
- Fracture prone? Blame your genes - Apr 22, 2012
Tags: basel switzerland, bone fracture, bone loss, boston university medical, boston university medical center, case control, contraceptive, depot medroxyprogesterone acetate, dmpa, estrogens, florence italy, fracture risk, jabs, lower estrogen levels, medroxyprogesterone, oral contraceptives, previous research, progestin, university medical center, world congress